Cancer Communications

Articles

Content type: Original article
| 1 November 2018

Famitinib in combination with concurrent chemoradiotherapy in patients with locoregionally advanced nasopharyngeal carcinoma: a phase 1, open-label, dose-escalation Study

Authors: Qiuyan Chen, Linquan Tang, Na Liu, Feng Han, Ling Guo, Shanshan Guo, Jianwei Wang, Huai Liu, Yanfang Ye, Lu Zhang, Liting Liu, Pan Wang, Yingqin Li, Qingmei He, Xiaoqun Yang, Qingnan Tang…
Content type: Editorial
| 30 October 2018

Metabolic features of cancer cells

Authors: Yugang Wang, Yan Xia and Zhimin Lu
Content type: Original article
| 26 October 2018

DUXAP8, a pseudogene derived lncRNA, promotes growth of pancreatic carcinoma cells by epigenetically silencing CDKN1A and KLF2

Authors: Yifan Lian, Jiebin Yang, Yikai Lian, Chuangxing Xiao, Xuezhen Hu and Hongzhi Xu
Content type: Review
| 26 October 2018

Nonmetabolic functions of metabolic enzymes in cancer development

Authors: Sean Lu and Yugang Wang
Content type: Original article
| 19 October 2018

IL-2Rα up-regulation is mediated by latent membrane protein 1 and promotes lymphomagenesis and chemotherapy resistance in natural killer/T-cell lymphoma

Authors: Liang Wang, Xi-wen Bi, Yu-jia Zhu, Ying-zhi He, Qiu-yu Lai, Zhong-jun Xia and Qing-qing Cai

Most recent articles RSS

View all articles

Content type: Review
| 2 July 2015

Predictive biomarkers in precision medicine and drug development against lung cancer

Authors: Bingliang Fang, Reza J Mehran, John V Heymach and Stephen G Swisher
Content type: Original article
| 10 August 2015

The prognostic value of serum C-reactive protein-bound serum amyloid A in early-stage lung cancer

Authors: Xue-Yan Zhang, Ge Zhang, Ying Jiang, Dan Liu, Man-Zhi Li, Qian Zhong, Shan-Qi Zeng, Wan-Li Liu and Mu-Sheng Zeng
Content type: Original article
| 12 August 2015

Subdivision of M category for nasopharyngeal carcinoma with synchronous metastasis: time to expand the M categorization system

Authors: Lu-Jun Shen, Si-Yang Wang, Guo-Feng Xie, Qi Zeng, Chen Chen, An-Nan Dong, Zhi-Mei Huang, Chang-Chuan Pan, Yun-Fei Xia and Pei-Hong Wu
Content type: Original article
| 15 August 2015

Cytochrome b5 reductase 2 suppresses tumor formation in nasopharyngeal carcinoma by attenuating angiogenesis

Authors: Huixin Ming, Ying Lan, Feng He, Xue Xiao, Xiaoying Zhou, Zhe Zhang, Ping Li and Guangwu Huang
Content type: Review
| 7 April 2016

Cell-free circulating tumor DNA in cancer

Authors: Zhen Qin, Vladimir A. Ljubimov, Cuiqi Zhou, Yunguang Tong and Jimin Liang

Most accessed articles RSS

View all articles

2018

Thematic series
Boron Neutron Capture Therapy of Cancer
Edited by Rolf F. Barth

2017

Thematic series
Tumor Metastasis
Edited by Jian Zhang and Chao-Nan Qian

2016

Thematic series
Gastric Cancer
Edited by Yun Dai and Li Yan

Thematic series
Tumor Angiogenesis
Edited by Francesco Pezzella and Chao-Nan Qian

2015

Thematic series
Lung Cancer
Edited by Lin Yan and Wei Zhang

Archival content

To browse articles published in the journal prior to March 2015, please visit the Sun Yat-sen University Cancer Center website.

Important notice

We would like to inform you that Chinese Journal of Cancer has changed the title to Cancer Communications on 1^st March 2018.

Thematic series

Boron Neutron Capture Therapy of Cancer
Edited by Rolf F. Barth

Tumor metastasis
Edited by: Jian Zhang and Chao-Nan Qian

Aims and scope

Cancer Communications is an open access, peer-reviewed online journal that encompasses basic, clinical, and translational cancer research. The journal welcomes submissions concerning clinical trials, epidemiology, molecular and cellular biology, and genetics.

Editor-in-Chief

Prof Rui-Hua Xu, Sun Yat-sen University Cancer Center, China

Information for authors

Cancer Communications offers waivers to authors for selected high quality articles. For rapid feedback on the potential suitability of an article for waiver, please send a pre-submission enquiry to the editorial office, providing the article title, abstract and a brief cover letter.

Cancer Communications

Articles

Famitinib in combination with concurrent chemoradiotherapy in patients with locoregionally advanced nasopharyngeal carcinoma: a phase 1, open-label, dose-escalation Study

Metabolic features of cancer cells

DUXAP8, a pseudogene derived lncRNA, promotes growth of pancreatic carcinoma cells by epigenetically silencing CDKN1A and KLF2

Nonmetabolic functions of metabolic enzymes in cancer development

IL-2Rα up-regulation is mediated by latent membrane protein 1 and promotes lymphomagenesis and chemotherapy resistance in natural killer/T-cell lymphoma

Predictive biomarkers in precision medicine and drug development against lung cancer

The prognostic value of serum C-reactive protein-bound serum amyloid A in early-stage lung cancer

Subdivision of M category for nasopharyngeal carcinoma with synchronous metastasis: time to expand the M categorization system

Cytochrome b5 reductase 2 suppresses tumor formation in nasopharyngeal carcinoma by attenuating angiogenesis

Cell-free circulating tumor DNA in cancer

2018

2017

2016

2015

Archival content

Important notice

Thematic series

Aims and scope

Editor-in-Chief

Information for authors

Affiliated with

Follow

2017 Journal Metrics

Cancer Communications

Contact us